# Specialised - Human Cell Line Recombinant Factor VIII

> Pre-procurement notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS ENGLAND](/buyers/nhs-england/contract-awards)
- Tender value: £15,000,000
- Published: 4 November 2019
- Planned start: 1 July 2020
- Planned end: 30 June 2021
- Stage: pre_procurement
- Notice ID: 6dde51f3-9e23-4fec-8616-065185af657c-323630
- OCID: ocds-b5fd17-adabd2fa-7ac9-4d90-89e0-e244a9957a0a

## Description

Human Cell Line Recombinant Factor VIII

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/6dde51f3-9e23-4fec-8616-065185af657c-323630)